Bang Zheng

Assistant Professor, PhD Supervisor
zhengbang2@bjmu.edu.cn
No. 38 Xueyuan Road, Haidian District, Beijing, China
Peking University

Personal profile

Dr. Zheng Bang is currently an Assistant Professor and PhD supervisor at the School of Public Health, Peking University. He also serves as an Honorary Assistant Professor at the London School of Hygiene & Tropical Medicine and an Honorary Research Associate at Imperial College London. He obtained his Bachelor's and Master's degrees at the School of Public Health, Peking University, in 2017 (supervised by Professor Liming Li) and completed his PhD at Imperial College London in 2021 (supervised by Professor Lefkos Middleton). In recent years, he has published over 30 papers as the first author (including co-first author) or corresponding author in journals such as BMJ, Nature Communications, Lancet Regional Health–Europe, Alzheimer's & Dementia, Diabetes Care, and eClinicalMedicine. His publications include three ESI top 1% highly cited papers and one ESI top 0.1% hot paper.

Main research directions

Chronic Disease Epidemiology and Pharmacoepidemiology based on large-scale cohorts and electronic health record databases.

Representative scientific research projects

Information not available

10 representative papers

[1] Zheng B, Green ACA, Tazare J, et al. Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform. BMJ. 2022,379:e071932.

[2] Zheng B, Su B, Price G, et al. Glycaemic control, diabetic complications and risk of dementia in patients with diabetes: results from a large UK cohort study. Diabetes Care. 2021,44(7):1556-1563.

[3] Zheng B, Su B, Ahmadi-Abhari S, et al. Dementia risk in patients with type 2 diabetes: comparing Metformin with no pharmacological treatment. Alzheimer's & Dementia. 2023,19(12):5681-5689.

[4] Zheng B, Tazare J, Nab L, et al. Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform. Lancet Regional Health – Europe. 2023,34:100741.

[5] Zheng B*, Vivaldi G*, Daines L, et al. Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls. Lancet Regional Health – Europe. 2023,29:100635. * Co-first author.

[6] Charpignon M*, Vakulenko-Lagun B*, Zheng B*, et al. Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia. Nature Communications. 2022;13:7652. * Co-first author

[7] Han Q, Zheng B*, Cristea M, et al. Trust in government regarding COVID-19 and its associations with preventive health behaviour and prosocial behaviour during the pandemic: a cross-sectional and longitudinal study. Psychological Medicine. 2023,53(1):149-159. * Corresponding author.

[8] Zheng B, Tal R, Yang ZR, et al. Cortisol hypersecretion and the risk of Alzheimer’s disease: a systematic review and meta-analysis. Ageing Research Reviews. 2020,64:101171.

[9] Zheng B, Udeh-Momoh C, Watermeyer T, et al. Practice effect of repeated cognitive tests among older adults: associations with brain amyloid pathology and other influencing factors. Frontiers in Aging Neuroscience. 2022,14:909614.

[10] Zheng B, Yu C, Lv J, et al.; China Kadoorie Biobank Collaborative Group. Insomnia symptoms and risk of cardiovascular diseases among 0.5 million adults: a 10-year cohort. Neurology. 2019,93(23):e2110-e2120.